- call +1-201-465-4211
- email sales@mrinsights.biz
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
Scope of the Report:
This report focuses on the Contraceptives Drugs and Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Contraceptives Drugs and Devices is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 30100 million US$ in 2023, from 19000 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market Segment by Applications, can be divided into
Female
Male
There are 15 Chapters to deeply display the global Contraceptives Drugs and Devices market.
Chapter 1, to describe Contraceptives Drugs and Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Contraceptives Drugs and Devices, with sales, revenue, and price of Contraceptives Drugs and Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Contraceptives Drugs and Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Contraceptives Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Contraceptives Drugs and Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Contraceptives Drugs and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.2.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.3 Market Analysis by Applications
1.3.1 Female
1.3.2 Male
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Business Overview
2.1.2 Contraceptives Drugs and Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Church & Dwight Co. Inc
2.2.1 Business Overview
2.2.2 Contraceptives Drugs and Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Reckitt Benckiser Plc
2.3.1 Business Overview
2.3.2 Contraceptives Drugs and Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer, Inc
2.4.1 Business Overview
2.4.2 Contraceptives Drugs and Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer AG
2.5.1 Business Overview
2.5.2 Contraceptives Drugs and Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mayer Laboratories, Inc
2.6.1 Business Overview
2.6.2 Contraceptives Drugs and Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 The Female Health Company
2.7.1 Business Overview
2.7.2 Contraceptives Drugs and Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cooper Surgical, Inc
2.8.1 Business Overview
2.8.2 Contraceptives Drugs and Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Allergan plc
2.9.1 Business Overview
2.9.2 Contraceptives Drugs and Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cipla Limited
2.10.1 Business Overview
2.10.2 Contraceptives Drugs and Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Merck & Co. Inc
2.11.1 Business Overview
2.11.2 Contraceptives Drugs and Devices Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Contraceptives Drugs and Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Contraceptives Drugs and Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Contraceptives Drugs and Devices Market Analysis by Regions
4.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
4.3 Europe Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
4.5 South America Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5 North America Contraceptives Drugs and Devices by Countries
5.1 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Contraceptives Drugs and Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Contraceptives Drugs and Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5.3 Canada Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6 Europe Contraceptives Drugs and Devices by Countries
6.1 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Contraceptives Drugs and Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Contraceptives Drugs and Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.3 UK Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.4 France Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.5 Russia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
6.6 Italy Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Contraceptives Drugs and Devices by Countries
7.1 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.3 Japan Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.4 Korea Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.5 India Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8 South America Contraceptives Drugs and Devices by Countries
8.1 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Contraceptives Drugs and Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Contraceptives Drugs and Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Contraceptives Drugs and Devices by Countries
9.1 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Contraceptives Drugs and Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Contraceptives Drugs and Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.3 UAE Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
10 Global Contraceptives Drugs and Devices Market Segment by Type
10.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2013-2018)
10.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth and Price
10.2.1 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth (2013-2018)
10.2.2 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Price (2013-2018)
10.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth and Price
10.3.1 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth (2013-2018)
10.3.2 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Price (2013-2018)
11 Global Contraceptives Drugs and Devices Market Segment by Application
11.1 Global Contraceptives Drugs and Devices Sales Market Share by Application (2013-2018)
11.2 Female Sales Growth (2013-2018)
11.3 Male Sales Growth (2013-2018)
12 Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.1 Global Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Contraceptives Drugs and Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.2 Europe Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.4 South America Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Contraceptives Drugs and Devices Market Forecast (2018-2023)
12.3 Contraceptives Drugs and Devices Market Forecast by Type (2018-2023)
12.3.1 Global Contraceptives Drugs and Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Contraceptives Drugs and Devices Market Share Forecast by Type (2018-2023)
12.4 Contraceptives Drugs and Devices Market Forecast by Application (2018-2023)
12.4.1 Global Contraceptives Drugs and Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Contraceptives Drugs and Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Contraceptives Drugs and Devices Picture
Table Product Specifications of Contraceptives Drugs and Devices
Figure Global Sales Market Share of Contraceptives Drugs an
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
